KBC Securities - KONINKLIJKE DSM N.V. (DSFIR) ... Morning Notes : DSFIR NA, TINC BB, ONWD BB

Report

KBC Securities

Hilde Van Boxstael ...

Sharad Kumar S.P
Thomas Vranken
Wim Hoste
Wim Lewi

Morning Notes : DSFIR NA, TINC BB, ONWD BB

: DSFIR NA, TINC BB, ONWD BB

21/10/2024 1 EN

Underlyings

KONINKLIJKE DSM N.V.

See profile

CH1216478797 Euronext Amsterdam Netherlands

ONWARD MEDICAL NV

See profile

NL0015000HT4 Euronext Brussels Netherlands

TINC Comm. VA

TINC Comm VA. Tinc Comm VA, also known as TINC, is a Belgium-based company focusing on investments in Infrastructure Asset Companies holding capitalintensive Infrastructure Assets providing services and generating cash flows of a long term sustainable nature. The Initial Investment Portfolio of the Company includes investments in over 10 Infrastructure Asset Companies holding underlying Infrastructure Assets in public private partnerships (PPP), energy and real assets in Belgium and the Netherlands, including Strorm and Brabo 1, among others. It operates through Storm Holding 4 NV.

See profile

BE0974282148 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Hilde Van Boxstael

Sharad Kumar S.P

Thomas Vranken

Wim Hoste

Wim Lewi

Other Reports on these Companies

KBC Securities

Morning Notes : AKZA NA, CMBT BB, FAGR BB, HEIA NA, SEQUA BB, ONWD BB

: AKZA NA, CMBT BB, FAGR BB, HEIA NA, SEQUA BB, ONWD BB

15h / 25m 15h / 25m 1 EN

KBC Securities

Onward Medical Launches capital increase for indicative amount of € c.40m

Onward launches a capital increase for an indicative amount of € c.40m, including a € 22.5m cornerstone investment from Ottobock, a global player in the fields of prosthetics, orthotics and exoskeleton technology. Euronext halts trading during the bookbuilding period to allow broader investor participation. Due to the transaction, we temporarily suspend coverage.

16h 16h 1 EN

GlobeNewsWire

ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA

ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA NE PAS DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, AU CANADA, EN AUSTRALIE OU AU JAPON OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION OU LA DIFFUSION SERAIT ILLÉGALE. D'AUTRES RESTRICTIONS SONT APPLICABLES. VEUILLEZ CONSULTER L'AVIS IMPORTANT À LA FIN DU COMMUNIQUÉ DE PRESSE. CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN S...

October 22, 2024 October 22, 2024 1 EN

Akzo Nobel Conference call feedback

Below are the highlights from the conference call. Akzo's 3Q adjusted EBITDA dropped by 5% which was close to our forecasts and 2% below consensus. Akzo adjusted its FY24 adjusted EBITDA guidance from ‘towards the lower end of a € 1.5-1.65bn range' to ‘around €1.5bn' with consensus at € 1499m and KBCS at € 1513m. FY24 leverage guidance is adjusted from around 2.3x to around 2.7x. The mid term guidance of at least 16% adjusted EBITDA margin is maintained, which represents a 260bps increase from 2023A. Taking into account the volatile track record and low structural growth, we maintain our Hold ...

13h / 10m 13h / 10m 1 EN

Wim Hoste

Wim Hoste

Heineken FIRST LOOK: 3Q volumes +0.7%, FY guidance maintained

Heineken's 3Q total volumes were up by 0.7% organically which was roughly in line with consensus (+0.6%) and better than our forecast(-0.7%). Unsurprisingly, FY guidance of 4-8% operating profit (beia) organic growth is maintained. We appreciate the beer category for the demonstrated pricing discipline, while premiumization and the exposure towards emerging economies offer further structural growth opportunities. Together with further savings potential (€ 400m pa in the coming years), we expect Heineken to demonstrate decent earnings growth in the next few years. Valuation remains attractive a...

15h / 1m 15h / 1m 1 EN

Kristof Samoy ... (+3)

Kristof Samoy
Thomas Vranken
Wim Hoste

Morning Notes : AKZA NA, CMBT BB, FAGR BB, HEIA NA, SEQUA BB, ONWD BB

: AKZA NA, CMBT BB, FAGR BB, HEIA NA, SEQUA BB, ONWD BB

15h / 25m 15h / 25m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : DSFIR NA, TINC BB, ONWD BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : AKZA NA, CMBT BB, FAGR BB, HEIA NA, SEQUA BB, ONWD BB

Onward Medical Launches capital increase for indicative amount of € c.40m

ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA

Akzo Nobel Conference call feedback

Heineken FIRST LOOK: 3Q volumes +0.7%, FY guidance maintained

Morning Notes : AKZA NA, CMBT BB, FAGR BB, HEIA NA, SEQUA BB, ONWD BB

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe